Chronic inflammatory diseases may also be affected by γc expression since increased serum concentrations of the soluble (s)γc variant were reported in human inflammatory bowel disease (23) and rheumatoid arthritis (24, 25). This evidence concerns the gene GC and rheumatoid arthritis.